Histology more predictive of ICI colitis outcome than clinical / endoscopic measures

New findings provide an important guide to the standardised evaluation of checkpoint inhibitor-induced colitis and how to stratify therapy. Robarts Histopathology Index [RHI] appears useful to predict which patients with immune checkpoint inhibitor (ICI) colitis will require biologic therapy and have adverse colitis outcomes, research found. A study of 149 patients from the US, Canada ...

Already a member?

Login to keep reading.

© 2021 the limbic